(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride [(4-(m-chlorfenylkarbamoyloxy)-2-butynyl)trimethylamoniumchlorid]
topical
- Terms
-
McN A-343
McN-A-343
McN-A343
McNeil A 343
Persistent link
https://www.medvik.cz/link/D008455
Definition
A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.
- Annotation
- McN stands for McNeil (a pharmaceut co)
- DUI
- D008455 MeSH Browser
- CUI
- M0013150
- CAS
- 2-Butyn-1-aminium, 4-((((3-chlorophenyl)amino)carbonyl)oxy)-N,N,N-trimethyl-, chloride
- Previous indexing
- Ammonium Compounds (1968-1974); Alkynes (1972-1974); Carbamates (1968-1974)
- History note
- 2005(1975)
- Public note
- 2005; see McN-A-343 1991-2004; see AMMONIUM COMPOUNDS 1975-1990
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.092.877.674.033
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
D02.455.326.397.325
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
D02.675.276.148
Bethanechol Compounds
D02.675.276.370
Emepronium
D02.675.276.569
Methantheline